World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 24 October 2016
Main ID:  NCT02934100
Date of registration: 11/10/2016
Prospective Registration: No
Primary sponsor: Medical Universtity of Lodz
Public title: Evaluation of Effectiveness of Selected Physical and Kinesiotherapeutic Methods in Patients With Lower Calcaneal Spur
Scientific title: Evaluation of Effectiveness of Selected Physical and Kinesiotherapeutic Methods in Patients With Lower Calcaneal Spur
Date of first enrolment: August 2016
Target sample size: 120
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT02934100
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment  
Phase:  N/A
Countries of recruitment
Poland
Contacts
Name:     Natalia Kociuga, master
Address: 
Telephone: +48609018609
Email: nkociuga@gmail.com
Affiliation: 
Name:     Natalia Kociuga, master
Address: 
Telephone: +48609018609
Email: nkociuga@gmail.com
Affiliation: 
Name:     Natalia Kociuga, master
Address: 
Telephone:
Email:
Affiliation:  Medical University of Lodz, Poland
Key inclusion & exclusion criteria

Inclusion Criteria:

- heel spur (calcaneal spur) diagnosed by a doctor based on X-ray examination,
diagnostic ultrasonography or MR

- signed informed consent

- heel pain for at least one month

Exclusion Criteria:

- pregnancy

- generalized acute infection (fever, cough, runny nose)

- local infection in the treated leg (wound, swelling)

- cancer

- injections of corticosteroids in the last six weeks

- pacemaker

- acute inflammation of the joints of the lower limbs

- inflammation of the veins

- Fresh fractures, post-traumatic

- osteoporosis

- Reynaud's disease

- Burger disease

- atherosclerosis

- after surgery condition before removing stitches

- High blood pressure

- after CT with contrast condition in the last two weeks

- The state of the lumbar puncture

- Strong imbalance

- Condition after myocardial infarction in the last six weeks

- Rheumatoid arthritis

- Ankylosing spondylitis

- Significant leg ulcers

- diabetes

- The risk of bleeding in the muscle tissue

- Thromboangiitis

- Hypersensitivity skin in the treated section

- A tendency to hemorrhage

- Pathological arrogance bone under the skin in the treated section

- Metal implants and surgical implants in the area of the lower limb subjected to
therapy



Age minimum: 40 Years
Age maximum: 75 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Heel Spur
Calcaneal Spur
Intervention(s)
Device: Sham LASER CTL1106MX
Device: Shock Master 300
Device: EVO US13 CosmoGamma
Device: Skanlab 25 BODYWAVE
Primary Outcome(s)
The Laitinen Pain Indicator Questionnaire [Time Frame: Change from before the treatment and right after the treatment. Also change from after the treatment at 2 months.]
The SF-36v2 Health Survey (SF-36v2) - Change [Time Frame: Change from before the treatment and right after the treatment. Also change from after the treatment at 2 months.]
The American Orthopedic Foot and Ankle Society Score (AOFAS) - Change [Time Frame: Change from before the treatment and right after the treatment. Also change from after the treatment at 2 months.]
Secondary Outcome(s)
Heel standing test [Time Frame: Patients will be screened using this scale three times: before treatment, immediately after its completion and two months after the end of therapy.]
Two weights test [Time Frame: Patients will be screened using this scale three times: before treatment, immediately after its completion and two months after the end of therapy.]
The Visual Analogue Scale [Time Frame: Patients will be screened using this scale three times: before treatment, immediately after its completion and two months after the end of therapy.]
Secondary ID(s)
RNN/47/16/KE
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history